English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

espanolEste trabajo indaga comparativamente en Argentina y Uruguay la evolucion de la mortalidad por enfermedades de transmision sexual (ETS) desde 2000, en el marco de los compromisos asumidos en la Agenda de Desarrollo post 2015. Para ello, se calculan y analizan tasas especificas de mortalidad con base en informacion de las Naciones Unidas. Aunque la mortalidad por ETS varia de forma disimil entre paises, los resultados senalan logros compartidos por su descenso en las primeras edades en relacion con el cancer de cuello uterino y el Virus de Inmunodeficiencia Humana (VIH) en varones de 15 a 44 anos. Como contrapartida, tambien evidencian desafios ligados al aumento de la tasa de mortalidad por VIH (uruguayas de 15 a 44 anos; varones desde los 45 anos) y Virus del Papiloma Humano (varones desde los 65 anos EnglishThis paper analyses, comparatively in Argentina and Uruguay, the evolution of mortality from sexually transmitted diseases (STDs) since 2000 in the context of the Post-2015 Development Agenda. Thus, specific mortality rates are calculated and analysed based on information from the United Nations. Although the general rate behaves differently between countries, the results show shared achievements referring the fall of the rate at the early stages, the rate due to cervical cancer and the 15-44 year-old rate from Human Immunodeficiency Virus (HIV; in Uruguay, only in males). Conversely, they also highlight challenges linked to a rise in the HIV (Uruguayan women aged 15-44; men aged 45 and over) and Human Papillomavirus rates (men aged 65 and over)

Mortalidad por enfermedades de transmisión sexual en Argentina y Uruguay